PUNE, India, July 5, 2016 /PRNewswire-iReach/ -- Global Gastrointestinal Market Partnering 2010 to 2016 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Photo - http://photos.prnewswire.com/prnh/20160705/386016
Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=80623
The report takes readers through the comprehensive Gastrointestinal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gastrointestinal deals.
The report presents financial deal terms values for Gastrointestinal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers t- analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Gastrointestinal dealmaking trends.
Chapter 1 provides an introduction t- the report.
Chapter 2 provides an overview of the trends in Gastrointestinal dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Gastrointestinal deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Gastrointestinal dealmakers, together with a full listing of deals t- which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access t- the contract.
Chapter 5 provides comprehensive access t- Gastrointestinal deals since 2010 where a deal contract is available, providing the user with direct access t- contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink t- an online version of the deal record contract document, providing easy access t- each contract document on demand.
Chapter 6 provides a comprehensive directory of all Gastrointestinal partnering deals by specific Gastrointestinal target announced since 2010. The chapter is organized by specific Gastrointestinal therapeutic target. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.
Complete research report of 700 pages with TOC is available at http://www.rnrmarketresearch.com/gastrointestinal-partnering-terms-and-agreements-market-report.html
Report scope
Global Gastrointestinal Partnering 2010 to 2016 is intended t- provide the reader with an in-depth understanding and access to Gastrointestinal trends and structure of deals entered int- by leading companies worldwide.
Global Gastrointestinal Partnering 2010 to 2016 includes:
Media Contact: Ritesh Tiwari, RnR Market Research, + 1 888 391 5441, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RnR Market Research
Advertisement
Photo - http://photos.prnewswire.com/prnh/20160705/386016
- Trends in Gastrointestinal partnering deals
- Financial deal terms for headline, upfront and royalty by stage of development
- Gastrointestinal partnering agreement structure
- Gastrointestinal partnering contract documents
- Top Gastrointestinal deals by value
- Most active Gastrointestinal dealmakers
Advertisement
Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=80623
The report takes readers through the comprehensive Gastrointestinal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gastrointestinal deals.
The report presents financial deal terms values for Gastrointestinal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers t- analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Gastrointestinal dealmaking trends.
Chapter 1 provides an introduction t- the report.
Chapter 2 provides an overview of the trends in Gastrointestinal dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Gastrointestinal deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Gastrointestinal dealmakers, together with a full listing of deals t- which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access t- the contract.
Chapter 5 provides comprehensive access t- Gastrointestinal deals since 2010 where a deal contract is available, providing the user with direct access t- contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink t- an online version of the deal record contract document, providing easy access t- each contract document on demand.
Chapter 6 provides a comprehensive directory of all Gastrointestinal partnering deals by specific Gastrointestinal target announced since 2010. The chapter is organized by specific Gastrointestinal therapeutic target. Each deal title links via Weblink t- an online version of the deal record and where available, the contract document, providing easy access t- each contract document on demand.
Complete research report of 700 pages with TOC is available at http://www.rnrmarketresearch.com/gastrointestinal-partnering-terms-and-agreements-market-report.html
Report scope
Global Gastrointestinal Partnering 2010 to 2016 is intended t- provide the reader with an in-depth understanding and access to Gastrointestinal trends and structure of deals entered int- by leading companies worldwide.
Global Gastrointestinal Partnering 2010 to 2016 includes:
- Trends in Gastrointestinal dealmaking in the biopharma industry since 2010
- Analysis of Gastrointestinal deal structure
- Access t- headline, upfront, milestone and royalty data
- Access t- hundreds of Gastrointestinal deal contract documents
- Comprehensive access t- over 3500 Gastrointestinal deal records
- The leading Gastrointestinal deals by value since 2010
- Most active Gastrointestinal dealmakers since 2010
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
Media Contact: Ritesh Tiwari, RnR Market Research, + 1 888 391 5441, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE RnR Market Research
